VCM
EGRX

Versant Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Versant Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7
Closed -$136 – 2088
2023
Q2 		$136 Buy
+7
New +$136 ﹤0.01% 2021
2022
Q4 		– Hold
0
– – – 1709
2022
Q3 		– Sell
-12
Closed -$1K – 1716
2022
Q2 		$1K Buy
+12
New +$1K ﹤0.01% 1395